AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2011
Dec 15, 2011
34931_dirs_2011-12-15_bb861c24-4002-4552-b637-de954110db43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-12-14
Reporting Person: Smith Robin L (Director, Chairman of Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-14 | Common Stock, $0.001 par value | P | 50000 | $0.5978 | Acquired | 1382750 | Direct |